Key result
Higher remnant cholesterol linked to ~2.8-fold higher ischemic heart disease risk independent of HDL.
Why the study?
Is elevated nonfasting remnant cholesterol a causal risk factor for ischemic heart disease independent of reduced HDL cholesterol?
Population
73,513 subjects from Copenhagen, including 11,984 with ischemic heart disease diagnosed between 1976 and 2010.
Design
Cohort, Mendelian randomization
Follow-up
between 1976 and 2010
Authors
Loading...
Elevated nonfasting remnant cholesterol is a causal risk factor for ischemic heart disease, independent of reduced HDL cholesterol.
Observational (n=73,513)
Mendelian randomization
Is elevated nonfasting remnant cholesterol a causal risk factor for ischemic heart disease independent of reduced HDL cholesterol?
Odds Ratio: 2.8 (95% CI 1.9–4.2)
Elevated nonfasting remnant cholesterol is a causal risk factor for ischemic heart disease, independent of reduced HDL cholesterol.
Varbo et al. (2012) conducted an observational in Ischemic heart disease (n=73,513). Elevated nonfasting remnant cholesterol vs. Lower nonfasting remnant cholesterol was evaluated on Ischemic heart disease (OR 2.8, 95% CI 1.9 to 4.2). A 1 mmol/l genetic increase in nonfasting remnant cholesterol was associated with a 2.8-fold causal risk for ischemic heart disease (OR 2.8; 95% CI 1.9 to 4.2), independent of reduced HDL.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: